250 related articles for article (PubMed ID: 8038709)
21. [The effect of IL-1 receptor antagonist on bleomycin-induced pulmonary fibrosis].
He B; Zhao GR; Liu XM
Zhonghua Jie He He Hu Xi Za Zhi; 1994 Feb; 17(1):21-3, 61. PubMed ID: 7521798
[TBL] [Abstract][Full Text] [Related]
22. Detection and characterization of IL-1 receptor antagonist in tissues from healthy rabbits: IL-1 receptor antagonist is probably involved in health.
Matsukawa A; Fukumoto T; Maeda T; Ohkawara S; Yoshinaga M
Cytokine; 1997 May; 9(5):307-15. PubMed ID: 9195129
[TBL] [Abstract][Full Text] [Related]
23. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-1 receptor antagonist gene therapy for arthritis.
Krishnan BR
Curr Opin Mol Ther; 1999 Aug; 1(4):454-7. PubMed ID: 11713759
[TBL] [Abstract][Full Text] [Related]
25. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra).
Conti P; Panara MR; Fridas S; Barbacane RC; Grilli A; Placido FC; Reale M; Fiore S
Cell Immunol; 1993 Apr; 147(2):446-57. PubMed ID: 8384086
[TBL] [Abstract][Full Text] [Related]
27. The role of interleukin-1 in host responses to infectious diseases.
Dinarello CA
Infect Agents Dis; 1992 Oct; 1(5):227-36. PubMed ID: 1344662
[TBL] [Abstract][Full Text] [Related]
28. Evidence of a pharmacogenomic response to interleukin-l receptor antagonist in rheumatoid arthritis.
Camp NJ; Cox A; di Giovine FS; McCabe D; Rich W; Duff GW
Genes Immun; 2005 Sep; 6(6):467-71. PubMed ID: 15931231
[TBL] [Abstract][Full Text] [Related]
29. Extracellular release of the type I intracellular IL-1 receptor antagonist from human airway epithelial cells: differential effects of IL-4, IL-13, IFN-gamma, and corticosteroids.
Levine SJ; Wu T; Shelhamer JH
J Immunol; 1997 Jun; 158(12):5949-57. PubMed ID: 9190949
[TBL] [Abstract][Full Text] [Related]
30. Prolonged systemic expression of human IL-1 receptor antagonist (hIL-1ra) in mice reconstituted with hematopoietic cells transduced with a retrovirus carrying the hIL-1ra cDNA.
Boggs SS; Patrene KD; Mueller GM; Evans CH; Doughty LA; Robbins PD
Gene Ther; 1995 Nov; 2(9):632-8. PubMed ID: 8548552
[TBL] [Abstract][Full Text] [Related]
31. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.
Jiang Y; Genant HK; Watt I; Cobby M; Bresnihan B; Aitchison R; McCabe D
Arthritis Rheum; 2000 May; 43(5):1001-9. PubMed ID: 10817552
[TBL] [Abstract][Full Text] [Related]
32. Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system.
Chirivi RG; Garofalo A; Padura IM; Mantovani A; Giavazzi R
Cancer Res; 1993 Oct; 53(20):5051-4. PubMed ID: 8267795
[TBL] [Abstract][Full Text] [Related]
33. Endogenous interleukin-1 receptor antagonist is neuroprotective.
Loddick SA; Wong ML; Bongiorno PB; Gold PW; Licinio J; Rothwell NJ
Biochem Biophys Res Commun; 1997 May; 234(1):211-5. PubMed ID: 9168991
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a low molecular weight isoform of IL-1 receptor antagonist.
Malyak M; Guthridge JM; Hance KR; Dower SK; Freed JH; Arend WP
J Immunol; 1998 Aug; 161(4):1997-2003. PubMed ID: 9712072
[TBL] [Abstract][Full Text] [Related]
35. [Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].
Zoń-Giebel A; Kotulska A; Giebel S; Cader SA; Kucharz EJ
Przegl Lek; 2002; 59(11):916-8. PubMed ID: 12715722
[TBL] [Abstract][Full Text] [Related]
36. Osteoarthritis gene therapy.
Evans CH; Gouze JN; Gouze E; Robbins PD; Ghivizzani SC
Gene Ther; 2004 Feb; 11(4):379-89. PubMed ID: 14724685
[TBL] [Abstract][Full Text] [Related]
37. Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsis.
Fisher CJ; Opal SM; Lowry SF; Sadoff JC; LaBrecque JF; Donovan HC; Lookabaugh JL; Lemke J; Pribble JP; Stromatt SC
Circ Shock; 1994 Sep; 44(1):1-8. PubMed ID: 7704933
[TBL] [Abstract][Full Text] [Related]
38. Monotonicity of interleukin-1 receptor-ligand binding with respect to antagonist in the presence of decoy receptor.
Gnacadja G; Shoshitaishvili A; Gresser MJ; Varnum B; Balaban D; Durst M; Vezina C; Li Y
J Theor Biol; 2007 Feb; 244(3):478-88. PubMed ID: 17011587
[TBL] [Abstract][Full Text] [Related]
39. Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancer.
Kopp WC; Urba WJ; Rager HC; Alvord WG; Oppenheim JJ; Smith JW; Longo DL
Clin Cancer Res; 1996 Mar; 2(3):501-6. PubMed ID: 9816196
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-1 receptor antagonist transiently impairs antibacterial defense but not survival in murine pneumococcal pneumonia.
Rijneveld AW; Florquin S; Speelman P; Edwards CK; Dinarello CA; van der Poll T
Eur Cytokine Netw; 2003; 14(4):242-5. PubMed ID: 14715417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
